Proceeding of the 32nd Annual General Meeting of the company under Regulation 30 of SEBI(Listing obligations and disclosure Requirements) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd held its 32nd Annual General Meeting on September 30, 2025 at 4:00 PM via video conferencing, chaired by CEO & Managing Director Mr. Sameer Goel. Five ordinary resolutions were considered, including adoption of audited financial statements for FY ending March 31, 2025, re-appointment of Mr. Sameer Goel as Director (retiring by rotation), appointment of M/s Neeraj Arora & Associates as Statutory Auditors until the 37th AGM, approval of Cost Auditors' remuneration for FY 2025-26, and appointment of Mr. Harish Kumar as Secretarial Auditor for five years (FY 2025-26 to FY 2029-30). E-voting was conducted via NSDL from September 27 to September 29, 2025, with one speaker shareholder (Mr. Pramod Jain) appreciating the company's performance. The meeting concluded at 4:13 PM with no unresolved shareholder queries.
This is a routine procedural disclosure confirming successful conduct of the AGM. All resolutions appear to be standard governance matters (auditor appointments, director re-appointment, accounts adoption) with no major strategic or capital-related decisions; no immediate impact on share price is expected.